Calista K Kringen is a Lincoln, Nebraska based nurse practitioner. Active license number of Calista K Kringen is 115259 in Nebraska. Her current practice location is 7100 Stephanie Ln, Lincoln. Patients can reach her at 402-484-9009 or can fax her at 402-483-4223. Calista K Kringen is APRN and her NPI number (Unique professional ID assigned by NPPES) is 1306665674. Calista K Kringen has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Calista K Kringen speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1306665674
NPI Enumeration Date:
04 Oct, 2024
NPI Last Update On:
04 Oct, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Calista K Kringen are as mentioned below.
License Number
Specialization
State
Status
115259
Nebraska
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Calista K Kringen 7100 Stephanie Ln, Lincoln, Nebraska
Zip:
68516-5332
Phone Number:
402-484-9009
Fax Number:
402-483-4223
Patients can reach Calista K Kringen at 7100 Stephanie Ln, Lincoln, Nebraska or can call to book an appointment on 402-484-9009.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 10 March, 2025.